Facebook Linkedin Twitter
Inside Precision Medicine Patients Aged 80 to 90 Respond to Standard-of-Care AML Treatment

Leukemia

Acute myeloid leukemia (AML)
News & Features

Patients Aged 80 to 90 Respond to Standard-of-Care AML Treatment

Chris Anderson -
0
Human blood cells, SEM
Molecular Dx

Seventeen More Genes Identified That Drive Age-Related Mutations in Blood Cells

Chris Anderson -
0
CAR T cell immunotherapy, illustration
News & Features

Altering CAR Proteins Improves T Cells’ Ability to Attack Solid Tumors

Chris Anderson -
0
Immune checkpoint inhibitors: Interaction between PD-1 and PD-L1 blocked by therapeutic antibodies
News & Features

New Immune Mechanism That Interferes with Checkpoint Inhibitors Revealed

Malorye Branca -
0
Sarcoma cells
News & Features

CAR T-Cell Therapy for Sarcoma Shows Early Promise

Helen Albert -
0
Dr. Diana Azzam & patient, Logan Jenner
News & Features

Functional Precision Medicine Leads to Better Cancer Treatments

Corinna Singleman, PhD -
0
Acute lymphoblastic leukaemia, illustration
News & Features

B-Cell Development Vulnerability in Leukemia Suggests Novel Combination Therapy

Chris Anderson -
0
cancer
News & Features

Obsidian Raises $160M+ to Advance Novel Solid Tumor Immunotherapy

Malorye Branca -
0
Leukaemia blood cells in CLL, SEM
News & Features

Danish Researchers Show Feasibility of Stopping Specialist Follow-Up in Low-Risk CLL patients

Chris Anderson -
0
Acute lymphoblastic leukemia ALL-L2 blood smear under light microscopy
News & Features

Genetic Variant Identified Responsible for Higher Risk of ALL in Latinos

Chris Anderson -
0
123...16Page 1 of 16

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine